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INTRODUCTION
Our institution is a designated emergency hospital, renovated
and relocated in March 2011.
From the opening of the hospital on March 1, 2011 to Novem-
ber 30, 2013, 119 patients with digestive organ malignancies had
undergone surgery, and 23 (19.3%) of them had hepato-biliary-
pancreatic malignant surgery.
To achieve radical resection (R0) with safe procedures of pan-
creatoduodenectomy (PD) and fewer complications after surgery,
since we have only several cases in our hospital, we decided to ver-
ify our surgical procedures for cancer of the pancreatic head region,
reconstruction methods and postoperative management, referring
to logical reports on highly evidence-based procedures conducted
in high-volume centers (HVC) in literatures.
We adopted the surgical procedures described in ‘Methods’ be-
low and performed PD in 6 cases. We report case series, regarding
the breakdown of the 6 cases, five cases were cancer of the pan-
creas and one was that of the papilla of Vater.
METHODS
1. Method of PD
No-touch (1) pylorus-resecting pancreatoduodenectomy (PrPD)
(2) with the hanging up and clamping technique (1) (Fig. 1A-D)
was performed (Fig. 2). The advantages of this method are as
follows,
 Able to operate the lesion without holding it by hand
 Able to prevent the leakage of cancer cells from the lesion
without Kocher’s mobilization
 Able to resect the retroperitoneal margin (RPM) systemati-
cally by forceps traction (Fig. 3)
 Able to ensure pathological exams to distinguish the nervous
plexus near SMA from the lymphatic tissue
 Able to reduce the incidence of postoperative delayed gastric
empting (DGE)
2. Reconstruction Methods (Fig. 4, 5)
 Pancreaticojejunostomy (Fig. 4)
a. Inner layer : Anastomosis of the pancreatic duct to the jejunal
mucosa by 8 to 11 interrupted sutures using 5-0 absorbable thread
with a lost stent (internal drainage) tube (3)
b. Outer layer : Kakita’s method (4) forming a seromuscular en-
velope with 5 to 6 interrupted sutures using 3-0 non-absorbable
thread (prolene)
Hepaticojejunostomy by one layer anastomosis with inter-
rupted sutures using 3-0 or 4-0 absorbable thread without stent
placement
 Antecolic gastrojejunostomy with 2- layer anastomosis (5)
Only one closed-suction tube (Jackson-Pratt tube) was placed
around the pancreaticojejunostomy
3. Postoperative Management
 Early Removal of Jackson-Pratt tube
Amylase value of the drainage fluid was measured on POD 1 and
POD 4, and after confirming that the amylase value was not more
than three times that of serum, the drainage tube was removed
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on POD 4.
 Introduction of enhanced recovery after surgery (ERAS)
Postoperative management was performed with ERAS method.
A nasogastric tube was not inserted intra-and postoperatively. Post-
operative pain was treated with a short -acting anesthetic and
epidural analgesia. Fluid was taken orally the next day, followed
by solid food intake on POD 3 and 4, and early mobilization and
walking were encouraged.
RESULTS
During 33 months from the opening of our new hospital, PD had
been performed in 6 patients. Table 1 describes the preoperative
characteristics of the 6 patients. The average age was 62.811.7
years old, and both the number of male patients and that of female
A B
C D
Fig. 1 No-touch pancreatoduodenectomy using the hunging up and clamping technique.
A. The anterior surfaces of the aorta is dissected bluntly to permit the passage of a tap
B. Since the left renal vein (LRV) is visible to the near comparatively when you pull the incised Treiz’ ligament with retractor, a position of the tape
is changed into the ventral side of LRV from the dorsal side
C. The tape is repositioned to the pancreatic side of the pancreatic side of the common hepatic artery and the SMV-PV cranially, and to the pan-
creatic side of the left renal vein and mesocolon caudally
D. Under traction of the vascular clamp, retroperitoneal margin is transected along with the right surface of SMA
Fig. 2 The stomach is divided at 2cm oral of the pylorus ring, and so
more 90% of the stomach can be preserved.
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patients were 3. As for the preoperative performance status (PS),
PS 0 is five people and PS 2 is one. Preoperative biliary drainage
was conducted in 5 patients who had jaundice. The surgical details
are shown in Table 2. The type of resection was PrPD in all cases,
the operative time was 371.257.53 min. The average bleeding vol-
ume was 464.6 ml123.1 and the intra-operative red cell trans-
fusion of 31.7 unit underwent in four cases. But blood transfusion
was not done in two cases. Table 3 describes the state of intra-
operative pancreas. The texture of the pancreas was hard with the
diameter of the main pancreatic duct (MPD) to be 4 or 3.5 mm in
2 cases, and soft with the diameter of MPD to be 2 mm or 3.5 mm
in 2 cases, respectively. Pancreatic transection was performed with
ultrasonic scalpel (SonoSurg) and surgical knife around the main
pancreatic duct.
The breakdown of the intra-and post-operative findings is as fol-
lows (Table 4). Cancer infiltration to the nervous plexus around
SMA was not verified histologically in all 6 cases, but cancer infil-
tration of the dissected peripancreatic tissue margin was recognized
in 3 of 6 cases. Therefore, the residual tumor was supposed to be
evaluated as R1 but not R0 for advanced cancer in these 3 cases.
Postoperative amylase levels in serum and drainage fluid are
shown in Table 5. The serum levels on POD 4 were restored to
the normal range except one which had no measurement. The amy-
lase level of drainage fluid on POD 4 was lower than on POD 1 in
4 cases. Although the level on POD 4 was slightly higher than on
POD 1 in 2 cases, they were almost in the normal range. According
A B
Retro-pancrea c head 
enveloped with the Gerota’s fascia (membrane picked up with tweezers)
IVC
SMV
duodenum
Fig. 3A. B The last procedure of the resection includes reversed Kocher’s mobilization. The posterior plane of the Georta’s fascia is dissected
medial to lateral direction.
Fig. 4 Pancreaticojejunostomy was performed by duct - to -mucosa, end- to -side anastomosis in all patients.
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to The International Study Group of Pancreatic Surgery (ISGPS),
all patients were without an amylase level higher than 3 times the
serum amylase level, so all were not difined it as postoperative pan-
creatic fistula (POPF).
Since the amylase levels of drainage fluid were not more than
three times those of serum, the drainage tube was removed on
POD 4 in all cases. And all patients didn’t need any surgical or ra-
diological therapy, so all were Grade I of The Clavien-Dindo Clas-
sification. The median hospital stay was 22 days.
No postoperative complications including pancreatic fistula, intra-
abdominal infection, and biliary leakage were observed in all cases
and there was no postoperative mortality as shown in Table 6.
Table 7 shows the prognosis of 6 cases with PD. Adjuvant sys-
temic chemotherapy could be started on POD 35 and earlier (24.5
days on average) in the 4 patients.
Although the case 1 was Stage III with R1 resection, he survived
for 39 months by the postoperative adjuvant chemotherapy. The
causes of the death were local recurrence, portal vein obstruction,
atrophy of the liver, and ascites. Two other patients with R1 resec-
tion died of recurrence around SMA or liver metastasis after 26
months and 10 months form the operation, respectively. In Case 4,
the patient who had R0 resection but developed N2 lymph node
metastasis died after 18 months from the operation due to recur-
rence around SMA. In Case 5, the patient developed dementia
postoperatively and went home on foot without permission (the dis-
tance was around 20 minutes on foot) on the 6th day after surgery.
Therefore, although it was Stage IVa, adjuvant chemotherapy was
not performed, and he died of local recurrence around SMA after
6 months from the surgery.
The results were summarized as follows ;
1. The drain could be removed 4 days after operation, and the
pancreatic fistula was not seen in all cases.
2. Solid food could be started on POD 4 after removing the drain.
3. Postoperative systemic chemotherapy could be started earlier.
4. Although we have a few PD cases a year in our institution, PD
could be conducted safely without complications by using the meth-
ods verified by quality RCT.
DISCUSSION
PD is an only effective treatment method for cancer of the pan-
creatic head region. Even for patients who underwent radical re-
section (R0), which was supposed to be curative, survival analysis
has revealed a poor survival rate because of cancer recurrence. The
most of the postoperative recurrent cases are due to hepatic me-
tastasis, local recurrence, and peritoneal dissemination. One of the
reasons for these is that cancer cells may be squeezed and shed
into the portal vein, peritoneal cavity or retroperitoneum after duo-
denal mobilization during operation by holding the pancreatic head
Fig. 5 Reconstruction after pylorus -ring resection PD.
Table 1 Preoperative Characteristics of 6 Patients
Age (yr) 62.811.7
Gender (M/F) 3/3
Performance Status (0/1/2) 5/0/1
Diabetes (yes/no) 2/4
Preoperative biliary drainage (yes/no) 5/1
Total bilirubin at hospitalization (mg/dl) 13.0212.0
Total bilirubin at just before operation (mg/dl) 2.491.24
Serum amylase level (IU/ML) 89.1753.43
Table 2 Surgical Details
Type of Resection PrPD in 6 cases
Operation time (min.SD) 371.257.53
Bleeding Volume (mlSD) 464.6123.1
Intraoperative Red Cells Transfusions (yes/no) 4/2
(USD) 31.7
Table 3 State of Residual Pancreas
No Case Location of cancer Size of Tumor mm (TS) Texture Diameter of MPD Number of Interupted Sutures in
Duct - to -duct
Anastomosis
Seromuscular
Anastomosis*
1 60s M Ph 32x35x35 (TS2) hard 4 mm 9 6
2 60s F Ph 58x30x21 (TS3) hard 3.5 mm 9 6
3 40s M Up 55x25x21 (TS3) soft 2 mm 8 6
4 70s F Ph 50x35x25 (TS3) soft 3.5 mm 9 6
5 70s M Ph 40x37x21 (TS2) soft 3.5 mm 11 5
6 60s F Papilla Vater 23x16 soft 2 mm 9 6
Ph : Head of Pancreas, Up : Uncinate Process,
MPD : main pancreatic duct , *Kakita method : forming a seromuscular envelope
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that contains tumors with the surgeon’s hand.
No-touch PD using the hanging up and clamping technique by
Hirota M, et al. (1) is considered to be a logical surgical method,
since this procedure needs no duodenal mobilization or holding
the pancreatic head. Therefore, we decided to adopt this method
(Fig 1).
Recently, Hirota M (6) reported good results that the 5-year sur-
vival rate of patients who received PD was 44%, and those of JPS-
stage III was 57%.
PpPD with preservation of the entire stomach had been popular-
ized in the late 1970s since the report on the treatment of chronic
pancreatitis by Traverso (7). The results of several randomized con-
trolled trials (RCT) or meta-analyses comparing PpPD and PD had
been reported, and the two procedures were equivalent in regard
to morbidity, mortality, and survival for the treatment of periampul-
lary cancer (8-13). Moreover, PpPD has been reported to reduce
Table 4 Description of Findings in 6 cases with PrPD
No Case Disease Ca. Inf. to SMA’s NP Ca. Inf. to DPM Stage (TNM) Assessment of Residual Tumor
1 60s M Ca. of Ph no + Stage(T3N1M0) R1
2 60s F Ca. of Ph no + Stagea (T3N2M0) R1
3 40s M Ca. of Up no + Stageb (T4N2M0) R1
4 70s F Ca. of Ph no - Stagea (T3N2M0) R0
5 70s M Ca. of Ph no - Stagea (T3N2M0) R0
6 60s F Ca.of Papilla Vater no - Stage(T3N0M0) R0
PrPD : Pylorus-resecting Pancreatoduodenectomy,
Ca. : cancer, Inf. : Infiltration, Ph : Head of Pancreas, Up : Uncinate Process,
SMA : Superior Mesenteric Artery, NP : Nerve Plexus, DPM : Dissected peripancreatic tissue Margin
Table 5 Amylase levels in Serum and Drainage Fluid
No Case Amylaze levels (IU/ML) Serum*/Drainage Fuluid Rempved Day of Drainage Tube Hospital Stay (Days)
POD 1 POD 4
1 60s M 157/109 125/169 4 33
2 60s F NM/229 50/106 4 14
3 40s M 79/2888 20/53 4 23
4 70s F 54/24 20/11 4 21
5 70s M 146/398 24/69 4 15
6 60s F 496/37 NM/65 4 80
Median hospital stay 22 days
* Normal range : 42～158 IU/ NM : not mesure
Table 6 Postoperative Complications (n=6)
Complications Number of Cases
Pancreatic fistula 0
Biliary leakage 0
Intra -abdominal infection 0
Wound infection 0
Delayed gastric empting 0
Mortality 0
Table 7 Postoperative chemotherapy and Prognosis
No Case Stage Location of ca. Assessment ofResidual Tumor Chemotherapy Drug & start date Reccurence and Prognosis
Drug Days (POD) Reccurence site Prognosis
1 60s M Stage Ph R1 GEM+S1 14 Paraaorta LN(19 month) 39 month dead
2 60s F Stagea Ph R1 GEM+S1 28 PL sma(12 month) 26 month dead
3 40s M Stageb Up R1 GEM+S1 35 Liver metastasis(2 month) 10 month dead
4 70s F Stagea Ph R0 S1 21 PL sma(18 month) 18 month alive
5 70s M Stagea Ph R0 ‐ ‐ PL sma(5 month) 6 month dead
6 60s F Stage Papilla Vater R0 ‐ ‐ ‐ 8 month alive
Ph : Head of Pancreas, Up : Uncinate Process, GEM : Gemcitabine,
S1 : S1 - tegafur -oxonate combination LN : Lymph node, PL sma : Plexus of superior mesenteric artery
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dumping, diarrhea, and bile reflux gastritis after gastrectomy and
improved the nutritional status of patients compared with PD with
distal gastrectomy (8, 11, 14). Therefore, PpPD had been generally
accepted as a surgical procedure for periampullary cancer and also
pancreatic cancer.
However, the reported overall incidence of delayed gastric emp-
tying (DGE) according to new definition from the International
Study Group of Pancreatic Surgery (ISGPS) is 33% to 46% (15-18)
and DGE is a frustrating complication. A RCT on whether PrPD
could reduce the incidence of DGE compared with PpPD was per-
formed by Kawai M, et al. (2), and showed that PrPD significantly
reduced the incidence of DGE compared with PpPD. And then, a
RCT conducted by Tani M, et al. (5) on whether antecolic duode-
nojejunostomy during PpPD could reduce the incidence of DGE
compared with retrocolic anastomosis showed that antecolic recon-
struction for duodenojejunostomy decreased DGE. Therefore, our
institution decided to employ PrPD and antecolic gastrojejunostomy.
PD is an aggressive surgery occasionally associated with pan-
creatic fistula and postoperative mortality. Pancreatic fistula, in
particular, is a severe complication of PD and may cause intra-
abdominal hemorrhage and postoperative mortality due to the au-
tolytic activity of pancreatic juice. Thus, our institution started to
use pancreaticojejunostomy with 2- layer anastomosis to prevent
pancreatic fistula. The inner layer anastomosis of the pancreatic
duct to the jejunal mucosa is performed and Kakita’s method (4)
is used for the outer layer anastomosis. Many surgeons have used
an external stent across pancreaticojejunostomy into the MPD to
prevent pancreatic fistula. In a RCT, Poon et al. (19) found that pa-
tients with an external tube had a significantly lower pancreatic
fistula rate compared with the non-stented group, and the pancre-
atic texture did not affect the incidence of pancreatic fistula. By
contrast, another RCT showed that pancreatic duct stenting did
not decrease the occurrence of pancreatic fistula in patients who
underwent PD, compared with non-stented patients (20). A RCT
conducted by Tani M, et al. (3) on whether internal drainage with
pancreaticojejunostomy is better than external drainage with pan-
creaticojejunostomy showed that the incidence of postoperative
complications including pancreatic fistula was not significantly dif-
ferent between internal and external drainage. However the me-
dian postoperative hospital stay in the internal drainage group was
significantly shorter than the external drainage group.
The International Study Group of Pancreatic Surgery (ISGPS)
has proposed a consensus on the definition and clinical grading of
postoperative pancreatic fistula (POPF). Actually, POPF represents
a failure of healing/sealing of a pancreatic-enteric anastomosis or
a parenchymal leak which is not directly related to an anastomo-
sis since distinguishing the two conditions is difficult. Thus, the all -
inclusive definition is a drain output of any measurable volume of
fluid on or after POD 3 with an amylase level higher than 3 times
the serum amylase level. Pancreatic fistula is also defined as follows :
Grade A, called “transient fistula,” which has no clinical impact on
postoperative course ; Grade B, required a change in management
or adjustment in the clinical pathway ; Grade C, a major change in
clinical management or deviation from the normal clinical pathway
(21, 22).
Then, to assess the value of prophylactic drainage, Kawai M, et
al. (23) prospectively assigned the patients into 2 groups : In group
1 (n=52), the drain was removed on POD 8 ; In group 2 (n=52),
the drain was removed on POD 4. Postoperative complications in
the 2 groups were compared, and it was showed that the rate of
pancreatic fistula was significantly lower in PDO 4 group (3.6%)
than POD 8 group (23%), (p=0.0038). In addition, Grade C was
not seen in POD 4 group. Also, a RCT on early versus late drain
removal after PD was performed by Bassi C et al. (24). Early drain
removal (on POD 3) in group A (n=57) and late drain removal
(POD 5 or beyond) in group B (n=57) were allocated at random
and compared. The rate of pancreatic fistula was 1.8% (Grade B in
1 case) in Group A versus 26.6% (Grade C in 15 cases, Grade B in
1 case, and Grade A in 7 cases) in Group B (p=0.0001). They con-
cluded that an intra-abdominal drain can be safely removed on
POD 3 after PD, and a prolonged period of drain insertion is asso-
ciated with a higher rate of postoperative complications with in-
creased hospital stay and costs.
According to the Pancreatic Cancer Clinical Practice Guidelines
(2013 Japanese version, Japan Pancreas Society) (25), complica-
tions tend to be fewer in the facilities where there are more than
a certain number of treatment cases and specialists. In addition,
those facilities conduct better management of complications, and
are recommended as Grade B. However, there is no clear descrip-
tion about ‘a certain number’ of operations. In one paper, medical
institutions with 19 or less cases in a year are determined to be a
low-volume center (LVC), and those with 20 or more cases in a
year to be high-volume center (HVC), and there is another paper
that determined medical institutions with 4 or less cases to be LVC,
those with 5 to 18 cases to be medium-volume center (MVC), and
those with 19 or more cases to be HVC. There seems to be no for-
mal and common definition for LVC, MVC and HVC. Some institu-
tions have specialists even if they are LVC.
Although we have a few PD cases a year in our institution, PD
can be conducted safely without complications by using the meth-
ods verified by the quality RCTs mentioned above. This indicates
that even if a medical institution is not HVC, PD can be performed
safely.
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